| Prevention of hepatic stellate cell activation using JQ1-and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis R Hassan, SN Tammam, S El Safy, M Abdel-Halim, A Asimakopoulou, ... European Journal of Pharmaceutics and Biopharmaceutics 134, 96-106, 2019 | 47 | 2019 |
| Targeting activated hepatic stellate cells using collagen-binding chitosan nanoparticles for siRNA delivery to fibrotic livers M Azzam, S El Safy, SA Abdelgelil, R Weiskirchen, A Asimakopoulou, ... Pharmaceutics 12 (6), 590, 2020 | 28 | 2020 |
| Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting S El-Safy, SN Tammam, M Abdel-Halim, ME Ali, J Youshia, ... European Journal of Pharmaceutics and Biopharmaceutics 148, 54-66, 2020 | 27 | 2020 |
| From passive targeting to personalized nanomedicine: multidimensional insights on nanoparticles’ interaction with the tumor microenvironment AA Sebak, BM El-Shenawy, S El-Safy, M El-Shazly Current Pharmaceutical Biotechnology 22 (11), 1444-1465, 2021 | 24 | 2021 |
| Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2 SN Tammam, S El Safy, S Ramadan, S Arjune, E Krakor, S Mathur Journal of Controlled Release 337, 258-284, 2021 | 12 | 2021 |
